Pediapharm Inc. (CVE:PDP – Get Free Report) shares shot up 1.7% during trading on Friday . The stock traded as high as C$0.31 and last traded at C$0.30. 26,000 shares were traded during trading, a decline of 74% from the average session volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Price Performance
The company has a current ratio of 1.12, a quick ratio of 0.71 and a debt-to-equity ratio of 186.87. The stock has a market cap of C$66.36 million and a P/E ratio of -4.11. The business has a 50-day simple moving average of C$0.30 and a 200 day simple moving average of C$0.30.
About Pediapharm
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Further Reading
- Five stocks we like better than Pediapharm
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Magnificent 7 Stocks Send a Dire Warning to Markets
- Why Invest in 5G? How to Invest in 5G Stocks
- Why Spotify Stock Still Has Room to Run in 2025
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Buy the Dip: Top Tech Stocks Analysts Say Are Undervalued
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
